α-Lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor κB ligand/osteoprotegerin ratio in human bone marrow stromal cells

Journal of Endocrinology

Volumn 185, Issue 3, 2005, Pages 401-413

  Koh, Jung Min ^c   Lee, Young Sun ^a   Byun, Chang Hyun ^a   Chang, Eun Ju ^b   Kim, Hyunsoo ^b   Kim, Yong Hee ^c   Kim, Hong Hee ^b   Kim, Ghi Su ^c  

^a Asan Institute for Life Sciences   (South Korea)

^b Seoul National University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; CYTOKINE ANTIBODY; MATRIX METALLOPROTEINASE INHIBITOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; THIOCTIC ACID;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEOMICS; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIVISION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOBLOTTING; MEMBRANE GLYCOPROTEINS; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STROMAL CELLS; THIOCTIC ACID;

EID: 21244502542     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05995     Document Type: Article

References (38)

1. Basu S, Michaelsson K, Olofsson H, Johansson S & Melhus H 2001 Association between oxidative stress and bone mineral density. Biochemical and Biophysical Research Communications 288 275-279.
2. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S et al. 1997 A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 729-733.
3. Boyle WJ, Simonet WS & Lacey DL 2003 Osteoclast differentiation and activation. Nature 423 337-342.
4. Chen YM, Ho SC, Lam SS, Ho SS & Woo JL 2003 Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. Journal of Clinical Endocrinology and Metabolism 88 4740-4747.
5. Chesneau V, Becherer JD, Zheng Y, Erdjument-Bromage H, Tempst P & Blobel CP 2003 Catalytic properties of ADAM19. Journal of Biological Chemistry 278 22331-22340.
6. Cohen MP, Shea E, Chen S & Shearman CW 2003 Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. Journal of Laboratory and Clinical Medicine 141 242-249.
7. Hall SL & Greendale GA 1998 The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcified Tissue International 63 183-189.
8. Henriksen EJ, Jacob S, Streeper RS, Fogt DL, Hokama JY & Tritschler HJ 1997 Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sciences 61 805-812.
9. Hofmann MA, Schiekofer S, Kanitz M, Klevesath MS, Joswig M, Lee V, Morcos M, Tritschler H, Ziegler R, Wahl P et al. 1998 Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21 1310-1316.
10. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, Treusch A, Morcos M, Weiss T, Borcea V et al. 1999 Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 42 222-232.
11. Hooper NM, Karran EH & Turner AJ 1997 Membrane protein secretases. Biochemical Journal 321 265-279.
12. Hsu H, Lacey DL, Dunstan CK, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I et al. 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. PNAS 96 3540-3545.
13. Ikeda T, Kasai M, Utsuyama M & Hirokawa K 2001 Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus. Endocrinology 142 1419-1426.
14. Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ & Henriksen EJ 1996 The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45 1024-1029.
15. Koyama H, Nakade O, Takada Y, Kaku T & Lau KH 2002 Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. Journal of Bone and Mineral Research 17 1219-1229.
16. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S et al. 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 165-176.
17. Landry F, Lombardo CR & Smith JW 2000 A method for application of samples to matrix-assisted laser desorption ionization time-of-flight targets that enhances peptide detection. Analytical Biochemistry 279 1-8.
18. Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL & Chambers TJ 2003 A crucial role for thiol antioxidants in estrogen-deficiency bone loss. Journal of Clinical Investigation 112 915-923.
19. Lee HA & Hughes DA 2002 Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA. Experimental Gerontology 37 401-410.
20. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH & Kim HH 2002 The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30 71-77.
21. Leveille SG, LaCroix AZ, Koepsell TD, Beresford SA, Van Belle G & Buchner DM 1997 Dietary vitamin C and bone mineral density in postmenopausal women in Washington State, USA. Journal of Epidemiology and Community Health 51 479-485.
22. Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y & Blobel CP 1999 Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. Journal of Biological Chemistry 274 13613-13618.
23. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R & Cherubini A 2003 Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. Journal of Clinical Endocrinology and Metabolism 88 1523-1527.
24. Melhus H, Michaelsson K, Holmberg L, Wolk A & Ljunghall S 1999 Smoking, antioxidant vitamins, and the risk of hip fracture. Journal of Bone and Mineral Research 14 129-135.
25. Packer L 1998 Alpha-lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury. Drug Metabolism Reviews 30 245-275.
26. Packer L, Witt EH & Tritschler HJ 1995 Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine 19 227-250.
27. Packer L, Tritschler HJ & Wessel K 1997 Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radical Biology and Medicine 22 359-378.
28. Roy S, Sen CK, Tritschler HJ & Packer L 1997 Modulation of cellular reducing equivalent homeostasis by alpha-lipoic acid. Mechanisms and implications for diabetes and ischemic injury. Biochemical Pharmacology 53 393-399.
29. Shevchenko A, Wilm M, Vorm O & Mann M 1996 Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Analytical Chemistry 68 850-858.
30. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H & Swick AG 2000 Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 92 73-78.
31. Suda T, Takahashi N & Martin TJ 1992 Modulation of osteoclast differentiation. Endocrine Reviews 13 66-80.
32. Suzuki J, Ikeda T, Kuroyama H, Seki S, Kasai M, Utsuyama M, Tatsumi M, Uematsu H & Hirokawa K 2004 Regulation of osteoclastogenesis by three human RANKL isoforms expressed in NIH3T3 cells. Biochemical and Biophysical Research Communications 314 1021-1027.
33. Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K & Suda T 2000 Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts. Endocrinology 141 4711-4719.
34. Wang MC, Luz Villa M, Marcus R & Kelsey JL 1997 Associations of vitamin C, calcium and protein with bone mass in postmenopausal Mexican American women. Osteoporosis International 7 533-558.
35. Wong BR, Josien R & Choi Y 1999 TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. Journal of Leukocyte Biology 65 715-724.
36. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A et al. 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. PNAS 95 3597-3602.
37. Zhang WJ & Frei B. 2001 Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. FASEB Journal 15 2423-2432.
38. Ziegler D, Reljanovic M, Mehnert H & Gries FA 1999 Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Experimental and Clinical Endocrinology and Diabetes 107 421-430.